# GUCA1B

## Overview
The GUCA1B gene encodes the protein guanylate cyclase-activating protein 2 (GCAP2), which is a calcium-binding protein crucial for the regulation of phototransduction in the retina. As a member of the EF-hand calcium-binding protein family, GCAP2 plays a pivotal role in modulating the activity of retinal guanylate cyclases, particularly in response to fluctuations in intracellular calcium levels. This modulation is essential for the synthesis of cyclic GMP (cGMP), a key intracellular messenger in visual signal transduction. The precise regulation of cGMP by GCAP2 is vital for maintaining normal photoreceptor function and visual acuity. Mutations in the GUCA1B gene have been linked to retinal degenerative diseases, such as autosomal dominant retinitis pigmentosa, highlighting the gene's significance in retinal health and disease (Sato2004Mutations; Sharon2018Genotypefunctionalphenotype).

## Structure
The GUCA1B gene encodes the guanylate cyclase-activating protein 2 (GCAP2), which plays a crucial role in phototransduction in the retina. The primary structure of GCAP2 consists of a sequence of amino acids that include EF-hand motifs, which are responsible for binding calcium ions (LópezBegines2018Molecular). These motifs are integral to the protein's function, as they influence its calcium sensitivity and subcellular localization (LópezBegines2018Molecular).

The secondary structure of GCAP2 includes alpha helices and beta sheets, which contribute to the protein's overall stability and function (LópezBegines2018Molecular). The tertiary structure involves the three-dimensional folding of these motifs, which is often stabilized by the calcium-binding EF-hand motifs (LópezBegines2018Molecular).

GCAP2 may also exhibit a quaternary structure, potentially forming dimers, which could influence its interactions with other proteins or its functional state (LópezBegines2018Molecular). Post-translational modifications such as myristoylation and phosphorylation play significant roles in the subcellular distribution and function of GCAP2. Myristoylation affects its membrane association, while phosphorylation can influence its localization within photoreceptor cells (LópezBegines2018Molecular).

## Function
The GUCA1B gene encodes guanylate cyclase-activating protein 2 (GCAP2), which plays a critical role in the regulation of phototransduction in retinal photoreceptor cells. GCAP2 is involved in modulating the activity of photoreceptor guanylate cyclases, specifically GC-E, in response to changes in intracellular calcium levels. This modulation is essential for the synthesis of cyclic GMP (cGMP), an intracellular messenger crucial for photoreceptor excitation and visual signal transduction (Sharon2018Genotypefunctionalphenotype).

In healthy human cells, GCAP2 functions by sensing reductions in calcium concentration, undergoing conformational changes in its Ca2+-free/Mg2+-bound state, which stimulates GC-E activity. This stimulation facilitates the restoration of cGMP levels after photoreceptor activation, allowing the photoreceptors to adapt to varying light conditions and maintain their ability to respond to light stimuli (Sharon2018Genotypefunctionalphenotype). The precise regulation of cGMP synthesis by GCAP2 is vital for normal photoreceptor function and visual acuity, highlighting its importance in the visual system. While mutations in GUCA1B are rare, they can be associated with retinal degeneration, underscoring the gene's role in maintaining retinal health (Sharon2018Genotypefunctionalphenotype).

## Clinical Significance
Mutations in the GUCA1B gene, which encodes guanylate cyclase-activating protein 2 (GCAP2), have been implicated in various forms of retinal dystrophies, particularly autosomal dominant retinitis pigmentosa (ADRP). A notable mutation, G157R, was identified in Japanese patients with ADRP. This mutation is associated with a range of retinal degeneration phenotypes, including diffuse pigmentary degeneration and macular degeneration, and exhibits variable phenotypic expression and incomplete penetrance. The G157R mutation was not found in patients with autosomal recessive retinitis pigmentosa (ARRP) or in unaffected individuals, suggesting its specific association with ADRP (Sato2004Mutations).

The study of GUCA1B mutations highlights a racial difference in the mutation spectrum between British and Japanese populations, indicating that the GCAP2 gene may be a candidate for retinal dystrophies in non-British populations (Sato2004Mutations). Additionally, the study identified other genetic variations, such as the T87I mutation, which did not segregate with the disease, suggesting it might be a polymorphism rather than a causative mutation (Sato2004Mutations). These findings underscore the complexity of genetic factors contributing to retinal diseases associated with GUCA1B mutations.

## Interactions
The GUCA1B gene encodes guanylate cyclase-activating protein 2 (GCAP2), which is involved in the regulation of phototransduction in the retina. GCAP2 is a calcium-binding protein that interacts with membrane guanylate cyclase isozymes, specifically retGC-1 and retGC-2, to modulate their activity in response to changes in calcium ion concentrations. This interaction is crucial for the recovery phase of visual signal transduction, as it helps restore the dark state of photoreceptor cells after exposure to light (Sato2004Mutations).

Mutations in the GUCA1B gene, such as the G157R mutation, have been associated with autosomal dominant retinal dystrophies, including retinitis pigmentosa. This mutation results in an amino acid substitution that affects the protein's function, leading to variable phenotypic expressions of retinal degeneration (Sato2004Mutations). The study of these mutations highlights the importance of GCAP2's interactions with guanylate cyclase enzymes in maintaining normal visual function and suggests that disruptions in these interactions can contribute to retinal diseases. The research also indicates a racial difference in the mutation spectrum of the GCAP2 gene between different populations, which may influence the prevalence and expression of related retinal disorders (Sato2004Mutations).


## References


[1. (Sato2004Mutations) Motoya Sato, Mitsuru Nakazawa, Tomoaki Usui, Naoyuki Tanimoto, Haruki Abe, and Hiroshi Ohguro. Mutations in the gene coding for guanylate cyclase-activating protein 2 (guca1b gene) in patients with autosomal dominant retinal dystrophies. Graefe’s Archive for Clinical and Experimental Ophthalmology, 243(3):235–242, September 2004. URL: http://dx.doi.org/10.1007/s00417-004-1015-7, doi:10.1007/s00417-004-1015-7. This article has 42 citations.](https://doi.org/10.1007/s00417-004-1015-7)

[2. (Sharon2018Genotypefunctionalphenotype) Dror Sharon, Hanna Wimberg, Yael Kinarty, and Karl-Wilhelm Koch. Genotype-functional-phenotype correlations in photoreceptor guanylate cyclase (gc-e) encoded by gucy2d. Progress in Retinal and Eye Research, 63:69–91, March 2018. URL: http://dx.doi.org/10.1016/j.preteyeres.2017.10.003, doi:10.1016/j.preteyeres.2017.10.003. This article has 67 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.preteyeres.2017.10.003)

[3. (LópezBegines2018Molecular) Santiago López-Begines, Anna Plana-Bonamaisó, and Ana Méndez. Molecular determinants of guanylate cyclase activating protein subcellular distribution in photoreceptor cells of the retina. Scientific Reports, February 2018. URL: http://dx.doi.org/10.1038/s41598-018-20893-1, doi:10.1038/s41598-018-20893-1. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-018-20893-1)